Table 1 COVID-19 testing status by sociodemographic characteristics, risk category and risk criteria.

From: Comparison of COVID-19 outcomes among shielded and non-shielded populations

 

COVID-19 testing status

p value

Not tested

Tested

N = 1,299,206

N = 15,865

n (%)

n (%)

Age group (years)

  

< 0.0001

0–24

355,238 (99.49)

1822 (0.51)

 

25–44

410,408 (99.22)

3247 (0.78)

 

45–64

340,268 (98.65)

4660 (1.35)

 

≥ 65

193,292 (96.92)

6136 (3.08)

 

Sex

  

< 0.0001

Male

654,041 (99.01)

6569 (0.99)

 

Female

645,165 (98.58)

9296 (1.42)

 

Deprivation quintile

  

< 0.0001

1 (most deprived)

461,672 (98.67)

6211 (1.33)

 

2

230,402 (98.75)

2921 (1.25)

 

3

194,702 (98.90)

2175 (1.10)

 

4

173,456 (98.93)

1883 (1.07)

 

5 (most affluent)

238,974 (98.89)

2675 (1.11)

 

Risk category

  

< 0.0001

Low

928,420 (99.27)

6819 (0.73)

 

Moderate

345,913 (97.97)

7172 (2.03)

 

Shielded

24,873 (92.99)

1874 (7.01)

 

Moderate risk criteria

Chronic respiratory disease

149,325 (98.33)

2540 (1.67)

< 0.0001

Heart disease

46,728 (96.21)

1843 (3.79)

< 0.0001

Hypertension

156,286 (97.55)

3929 (2.45)

< 0.0001

Diabetes

62,482 (97.09)

1876 (2.91)

< 0.0001

Weakened immune system

1140 (95.40)

55 (4.60)

< 0.0001

≥ 70 years of age

134,305 (96.23)

5263 (3.77)

< 0.0001

Shielded criteria

Severe respiratory disease

17,146 (94.48)

1001 (5.52)

< 0.0001

Specific cancers

2075 (83.30)

416 (16.70)

< 0.0001

Pregnant with severe heart disease

< 5

0

Immunosuppressive therapy

5028 (94.00)

321 (6.00)

< 0.0001

Solid organ transplant

1149 (92.29)

96 (7.71)

< 0.0001

Rare diseases and inborn errors of metabolism

1623 (91.95)

142 (8.05)

< 0.0001

Renal dialysis

305 (64.21)

170 (35.79)

< 0.0001

  1. N number.